Get started
Author

Seiya Ohki

Observed name: Ohki, Seiya
ORCID: 0009-0006-5367-4844
Observed ORCID: 0009-0006-5367-4844
OpenAlex ID: A5002437238
Development and Validation of an LC–MS/MS-Based Method for Quantifying Urinary Endogenous 6-Hydroxymelatonin
2022 · Seiya Ohki, Miyu Kunimatsu, et al. · Chemical and Pharmaceutical Bulletin · 11
PDF
Development and biological characterization of the cyclic peptide cRGDTFI with potent binding affinity for integrins αvβ3 and αvβ5
2025 · Yuji Yamada, Seiya Ohki, et al. · Materials & Design · 3
Translational applicability of human blood-brain barrier spheroid models for the development of brain-penetrant therapeutic antibodies
2026 · Seiya Ohki, Tomoki Fukatsu, et al. · Fluids and Barriers of the CNS · 1
Functional assessment of immortalized human brain microvascular endothelial cells with different passage numbers: A case study for a prospective proposal on variability management of in vitro blood-brain barrier models
2025 · Seiya Ohki, Mei Fukuda, et al. · Drug Metabolism and Pharmacokinetics · 1
Cyclic SLS Peptide Fusion Enables Efficient Brain Delivery of Monoclonal Antibodies across the Blood−Brain Barrier
2026 · Kanna Kurashiki, Shoei Kameoka, et al. · Molecular Pharmaceutics
Corrigendum to “Development and biological characterization of the cyclic peptide cRGDTFI with potent binding affinity for integrins αvβ3 and αvβ5” [Mater. Des. 257 (2025) 114466]
2026 · Yuji Yamada, Seiya Ohki, et al. · Materials & Design
Translational applicability of human blood-brain barrier spheroid models for the development of brain-penetrant therapeutic antibodies
2026 · Ohki, Seiya, Fukatsu, Tomoki, et al. · Figshare
Additional file 1 of Translational applicability of human blood-brain barrier spheroid models for the development of brain-penetrant therapeutic antibodies
2026 · Ohki, Seiya, Fukatsu, Tomoki, et al. · Figshare
Multicellular spheroidal human blood-brain barrier models are a useful tool for characterization of brain-penetrating antibodies
2025 · Seiya Ohki, Kana Yamamoto, et al. · Drug Metabolism and Pharmacokinetics
Calculation of Human Melatonin Partial Metabolic Clearance in Healthy Adult Volunteers for Investigation of a Novel in Vivo CYP1A2 Phenotyping Method: A Pilot Study
2023 · Seiya Ohki, Shingo Ogawa, et al. · Biological and Pharmaceutical Bulletin
PDF
Works count: 10
Citation count: 16
H-index: 2
I10-index: 1
Year
Topic
Type